Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | TLR4 | O00206 | 1/20 | 0.35 |
| ▸ | NOS1 | P29475 | 2/20 | 0.34 |
| ▸ | NOS2 | P35228 | 2/20 | 0.34 |
| ▸ | DPP4 | P27487 | 3/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | SPHK1 | Q9NYA1 | 4/20 | 0.33 |
| ▸ | SPHK2 | Q9NRA0 | 3/20 | 0.33 |
| ▸ | NAAA | Q02083 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30448990 | 0.92 | SPHK1 (0.41) | CYP1A2LMNAMAPK1HTTSPHK1 | |
| SCHEMBL26554633 | 0.92 | SPHK1 (0.41) | CYP1A2LMNAMAPK1HTTSPHK1 | |
| Sulfuric Acid SCHEMBL5870557 | 0.89 | HTT (0.40) | CYP1A2LMNAMAPK1HTTMAPT | |
| Sulfuric Acid SCHEMBL5870555 | 0.89 | HTT (0.40) | CYP1A2LMNAMAPK1HTTMAPT | |
| SCHEMBL3965893 | 0.86 | NOS3 (0.33) | CYP1A2LMNAMAPK1MAPTNOS1 | |
| SCHEMBL3963226 | 0.86 | NOS3 (0.33) | CYP1A2LMNAMAPK1MAPTNOS1 | |
| SCHEMBL27824332 | 0.83 | CYP1A2 (0.43) | CYP1A2LMNAMAPK1HTTNOS1 | |
| SCHEMBL28153615 | 0.81 | CYP1A2 (0.59) | CYP1A2LMNAMAPK1HTTMAPT | |
| SCHEMBL21988093 | 0.80 | CYP1A2 (0.48) | CYP1A2LMNAMAPK1HTTMAPT | |
| SCHEMBL333152 | 0.77 | THRB (0.32) | NOS1NOS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1172906-C | Cyanoethylation of alicyclic hypodiamine | �����Ʒ�뻯ѧ��˾ | 2004-10-27 | — | — | CN | claimed |
| CN-1900057-A | Method for synthesizing amino sulfonic acid series amphoteric surfactant | UNIV TAIYUAN SCIENCE & ENG (CN) | 2007-01-24 | — | — | CN | disclosed |
| US-7057059-B2 | Tumor-inhibiting platinum (II) oxalate complexes | FAUSTUS FORSCHUNGS CIE. TRANSLATIONAL CANCER RESEARCH GMBH (DE) | 2006-06-06 | — | — | US | disclosed |
| US-20050143455-A1 | Tumor-inhibiting platinum (II) oxalate complexes | FAUSTUS FORSCHUNGS CIE. TRANSLATIONAL CANCER RESEARCH GMBH | 2005-06-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050143455-A1 | Tumor-inhibiting platinum (II) oxalate complexes | OXGR1, OAT, OXA1L | CYP1A2 1312/4885LMNA 4427/4885MAPK1 3993/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.